Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
7.3
166.04%
80%
—
150.46%
60%
—
5 Years
Score7.3
Net Growth166.04%
Net Trend80%
Net Income Consistency—
Rev Growth150.46%
Rev Trend60%
Revenue Consistency—
Protagonist Therapeutics Inc fundamental performance
Between 2020 and 2025, revenue grew from $ 28M to $ 46M and net income went from -$ 66M to -$ 130M. Revenue increased in 3 of those 5 years; net income in 4.
Protagonist Therapeutics Inc currently holds a 5-year HDB Score of 7.3 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 152.01 | — |
1 Year2025-08-12 | $ 54.53 | 178.76% |
5 Years2021-08-12 | $ 48.61 | 212.71% |
10 Years2016-08-12 | $ 11.57 | 13x |
All Time2016-08-11 | $ 11.70 | 12x |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | All Time2016-08-11 |
|---|---|---|---|---|---|
| Price | $ 152.01 | $ 54.53 | $ 48.61 | $ 11.57 | $ 11.70 |
| Return | — | 178.76% | 212.71% | 13x | 12x |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 68M | $ 82M | $ 782M |
| 2025 | $ 46M | -$ 130M | $ 567M |
| 2024 | $ 434M | $ 275M | $ 418M |
| 2023 | $ 60M | -$ 78M | $ 341M |
| 2022 | $ 26M | -$ 123M | $ 237M |
| 2021 | $ 27M | -$ 125M | $ 326M |
| 2020 | $ 28M | -$ 66M | $ 305M |
| 2019 | $ 231K | -$ 77M | $ 133M |
| 2018 | $ 30M | -$ 38M | $ 128M |
| 2017 | $ 20M | -$ 36M | $ 144M |
| IPO2016 | $ 0.00 | -$ 37M | $ 77M |
Explore beyond PTGX
You're looking at Protagonist Therapeutics Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
Explore other companies
- Healthcare Services Group IncHCSG· revenue grew in 80% of years
- Hyperfine IncHYPR· revenue grew in 100% of years
- Amneal Pharmaceuticals, Inc. Class A Common StockAMRX· revenue grew in 100% of years
- Tactile Systems Technology IncTCMD· revenue grew in 100% of years
- Oscar Health IncOSCR· revenue grew in 100% of years
